BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tiwari V, Kedia S, Garg SK, Rampal R, Mouli VP, Purwar A, Mitra DK, Das P, Dattagupta S, Makharia G, Acharya SK, Ahuja V. CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease. PLoS One. 2018;13:e0193433. [PMID: 29489879 DOI: 10.1371/journal.pone.0193433] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Maulahela H, Simadibrata M, Nelwan EJ, Rahadiani N, Renesteen E, Suwarti SWT, Anggraini YW. Recent advances in the diagnosis of intestinal tuberculosis. BMC Gastroenterol 2022;22:89. [PMID: 35227196 DOI: 10.1186/s12876-022-02171-7] [Reference Citation Analysis]
2 Roy S, Ghosh S, Banerjee M, Laha S, Bhattacharjee D, Sarkar R, Ray S, Banerjee A, Ghosh R, Halder A, Ghosh A, Chatterjee R, Datta S, Dhali GK, Banerjee S. A combination of circulating microRNA-375-3p and chemokines CCL11, CXCL12, and G-CSF differentiate Crohn's disease and intestinal tuberculosis. Sci Rep 2021;11:23303. [PMID: 34857759 DOI: 10.1038/s41598-021-02383-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Gupta A, Pratap Mouli V, Mohta S, Kante B, Kalaivani M, Madhu D, Sahu P, Kumar S, Sharma R, Sahni P, Das P, Gupta SD, Makharia G, Kedia S, Ahuja V. Antitubercular Therapy Given to Differentiate Crohn's Disease From Intestinal Tuberculosis Predisposes to Stricture Formation. J Crohns Colitis 2020;14:1611-8. [PMID: 32369567 DOI: 10.1093/ecco-jcc/jjaa091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Téllez-Navarrete NA, Ramon-Luing LA, Muñoz-Torrico M, Preciado-García M, Medina-Quero K, Hernandez-Pando R, Chavez-Galan L. Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time. Mol Med 2021;27:76. [PMID: 34261449 DOI: 10.1186/s10020-021-00320-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Kedia S, Ahuja V. Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion. JGH Open 2021;5:177-9. [PMID: 33553652 DOI: 10.1002/jgh3.12495] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Banerjee R, Pal P, Mak JWY, Ng SC. Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol 2020;5:1076-88. [PMID: 33181087 DOI: 10.1016/S2468-1253(20)30299-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Nayak SS, Shetty MV, Pai CG, Guruprasad KP, Satyamoorthy K. Apoptosis in peripheral blood lymphocytes in intestinal tuberculosis and Crohn's disease: Implications to diagnostic differentiation. Indian J Gastroenterol 2020;39:338-45. [PMID: 32803718 DOI: 10.1007/s12664-019-01011-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Sharma V. Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis. Expert Rev Gastroenterol Hepatol 2020;14:647-50. [PMID: 32552311 DOI: 10.1080/17474124.2020.1785870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Rampal R, Kedia S, Wari MN, Madhu D, Singh AK, Tiwari V, Mouli VP, Mohta S, Makharia G, Ahuja V. Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn's disease. Intest Res 2021;19:232-8. [PMID: 32375209 DOI: 10.5217/ir.2019.09181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kedia S, Das P, Madhusudhan KS, Dattagupta S, Sharma R, Sahni P, Makharia G, Ahuja V. Differentiating Crohn’s disease from intestinal tuberculosis. World J Gastroenterol 2019; 25(4): 418-432 [PMID: 30700939 DOI: 10.3748/wjg.v25.i4.418] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 35] [Article Influence: 20.3] [Reference Citation Analysis]
11 Ao C, Zeng K. The role of regulatory T cells in pathogenesis and therapy of human papillomavirus-related diseases, especially in cancer. Infect Genet Evol 2018;65:406-13. [PMID: 30172014 DOI: 10.1016/j.meegid.2018.08.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
12 Sabbagh P, Karkhah A, Nouri HR, Javanian M, Ebrahimpour S. The significance role of regulatory T cells in the persistence of infections by intracellular bacteria. Infect Genet Evol 2018;62:270-4. [PMID: 29751196 DOI: 10.1016/j.meegid.2018.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]